Collegium Pharmaceutical upgraded by Jefferies with a new price target
$COLL
Biotechnology: Pharmaceutical Preparations
Health Care
Jefferies upgraded Collegium Pharmaceutical from Hold to Buy and set a new price target of $44.00 from $41.00 previously